Gameto's $44 Million Series C Funding Revolutionizes Reproductive Care with New Stem Cell Trials Gameto, a pioneering biotech firm, secures $44 million to enhance reproductive health through innovative stem cell therapies. Learn about their groundbreaking trials!

Gameto's $44 Million Series C Funding Revolutionizes Reproductive Care with New Stem Cell Trials #United_States #Austin #stem_cell #Gameto #Fertilo